http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2848249-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d3ae1c5081972860d44222eb516aaea
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C251-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C249-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401
filingDate 2009-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1077c31bcaf20dfdb509dc80a44edbab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f884b04029a1c4726b00f58bc78dfba7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcf76e6e36daa0f6d1527ad52ee40eb8
publicationDate 2015-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2848249-A3
titleOfInvention Amino acid derivatives used as pharmaceutical substances
abstract The present invention relates to a method for improving the bioavailability and enabling the blood-brain barrier mobility of drugs which have at least one or more amidine, guanidine, N-hydroxyamidine (amidoxime) and N-hydroxyguanidine functions respectively and modified accordingly Drugs containing drugs.
priorityDate 2008-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9857932-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008009264-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3520
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136623549
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID80668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559377
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415973086
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484259

Total number of triples: 39.